Robert Besthof

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Robert Besthof
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Besthof:

Company Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Interim CEO Employee Stock Option 347,200 08 Mar 2022 Direct

Insider Reports Filed by Robert Besthof

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRXP NRX Pharmaceuticals, Inc. 08 Mar 2022 1 +$261,000 4 Interim CEO 10 Mar 2022, 15:04
NRXP NRX Pharmaceuticals, Inc. 16 Aug 2021 4 -$477,658 4 Chief Comm. & Patient Officer 02 Nov 2021, 16:04
NRXP NRX Pharmaceuticals, Inc. 24 May 2021 2 $0 4 Chief Comm. & Patient Officer 10 Jun 2021, 18:44
NRXP NRX Pharmaceuticals, Inc. 24 May 2021 0 $0 3 Chief Comm. & Patient Officer 10 Jun 2021, 18:29